Qureight Ltd.. (2/5/25). "Press Release: Qureight and Avalyn Launch Strategic Partnership in Progressive Pulmonary Fibrosis". |
2025-02-05 |
High-Tech Gründerfonds Management GmbH. (2/4/25). "Press Release: Akribion Therapeutics Exits from Stealth with €8m Seed Financing to pioneer RNA-guided, programmable cell depletion". |
2025-02-04 |
Coulter Partners. (2/4/25). "Press Release: Coulter Partners Places Chief Business Officer at Our Future Health". |
2025-02-04 |
Rentschler Biopharma SE. (1/30/25). "Press Release: Rentschler Biopharma Announces Strategic Realignment of Its Global Business Operations". Laupheim. |
2025-01-30 |
Quibim S.L.. (1/28/25). "Press Release: Quibim Announces $50 Million in Series A Financing, Led by Asabys and Buenavista, to Revolutionize Precision Medicine with AI-Powered Imaging Biomarkers". Valencia & New York, NY. |
2025-01-28 |
Coulter Partners. (1/23/25). "Press Release: Coulter Partners Secures CEO Placement for NeoPhore". |
2025-01-23 |
Circio Holding ASA. (1/21/25). "Press Release: 4basebio Partners with Circio to Build and Test circVec Synthetic DNA Vectors for Genetic Medicine and Vaccines". Oslo. |
2025-01-21 |
Cormica Ltd.. (1/20/25). "Press Release: Cormica Expands European Operations with Acquisition of Zwisler Laboratorium GmbH". |
2025-01-20 |
Owlstone Medical Ltd.. (1/15/25). "Press Release: Owlstone Medical Announces $27 Million USD First Close in Series E Financing Round". Cambridge. |
2025-01-15 |
Bioptimus SAS. (1/14/25). "Press Release: Bioptimus Hits $76M Funding Milestone and Prepares to Launch Groundbreaking Foundation Model for Biology". |
2025-01-14 |
GSK plc. (1/13/25). "Press Release: GSK Enters Agreement to Acquire IDRx, Inc.". London. |
2025-01-13 |
Windward Bio AG. (1/10/25). "Press Release: Windward Bio Launches With $200 Million Series A Financing to Develop Phase 2-Ready, Long-Acting Anti-TSLP Antibody With Best-in-Class Potential in Asthma and COPD". Basel. |
2025-01-10 |
Coave Therapeutics (Horama S.A.). (1/9/25). "Press Release: Coave Therapeutics Secures €32 Million ($33 Million) in Series A Financing to Advance its Next-Generation Genetic Medicines". Paris. |
2025-01-09 |
Oribiotech Ltd.. (1/9/25). "Press Release: Ori Biotech Expands Team to Advance IRO Commercialization and Industry Partnerships". London. |
2025-01-09 |
Medix Biochemica Oy. (1/8/25). "Press Release: Medix Biochemica Welcomes Stefan Schorling to Its Leadership Team". |
2025-01-08 |
Oribiotech Ltd.. (1/7/25). "Press Release: Ori Biotech Announces First Customer Deliveries of IRO to Leading CDMOs and Commercial CGT Manufacturers". London. |
2025-01-07 |
Ottimo Pharma Ltd.. (12/19/24). "Press Release: Ottimo Pharma Raises over $140 Million in Series A Financing". London & Boston, MA. |
2024-12-19 |
NeoPhore Ltd.. (12/16/24). "Press Release: NeoPhore Appoints Michael Shih as Chief Executive Officer". London. |
2024-12-16 |
2cureX AB. (12/16/24). "Press Release: 2cureX AB Announces the Appointment of Dan Honeywell as CEO, Ushering in a New Era of Commercial Expansion of Breakthrough Precision Oncology Products". |
2024-12-16 |
Andera Partners. (12/12/24). "Press Release: New York Life Investments and Its European Affiliate, Candriam, Announce Strategic Partnership with Andera Partners". New York, NY, Paris & Brussels. |
2024-12-12 |
BenevolentAI Ltd.. (12/11/24). "Press Release: BenevolentAI Unveils Major Strategic Overhaul with Return to Original Mission". London. |
2024-12-11 |
Siemens Healthineers AG. (12/10/24). "Press Release: Siemens Healthineers Acquires Advanced Accelerator Applications Molecular Imaging". |
2024-12-10 |
Selvita S.A.. (12/10/24). "Press Release: Selvita Strengthens Management Structure in Sales and Drug Development Segment". Kraków. |
2024-12-10 |
Relation Therapeutics Ltd.. (12/10/24). "Press Release: Relation Announces Two Strategic Collaborations with GSK to Advance Therapeutics for Fibrotic Diseases and Osteoarthritis". London. |
2024-12-10 |
Oribiotech Ltd.. (12/10/24). "Press Release: Ori Biotech and Fresenius Kabi Collaborate to Advance Modular, Scalable Manufacturing of Cell and Gene Therapies". London & Bad Homburg. |
2024-12-10 |
Aqemia SAS. (12/10/24). "Press Release: Aqemia Hits $100 Million Funding Milestone, Paving Way to Clinical Trials and Global Expansion Starting with London, UK". Paris & London. |
2024-12-10 |
Newcells Biotech Ltd.. (12/5/24). "Press Release: Newcells Biotech Raises Additional Funding from Investors". Newcastle. |
2024-12-05 |
ViveBiotech S.L.. (12/4/24). "Press Release: ViveBiotech Secures Growth Investment from Ampersand Capital Partners to Expand Lentiviral Vector Development and Manufacturing Capabilities". |
2024-12-04 |
Abselion (HexagonFab Ltd.). (12/4/24). "Press Release: Abselion Raises £6.6 Million Led by M Ventures to Bring Disruptive At-line Protein Analyser, Amperia, to Market". Cambridge. |
2024-12-04 |
Orbit Discovery Ltd.. (12/3/24). "Press Release: Orbit Discovery and Evergreen Theragnostics Expand Research Collaboration to Advance Targeted Therapeutics Development". Oxford & Springfield, NJ. |
2024-12-03 |
Cradle Bio B.V.. (11/26/24). "Press Release: Cradle Raises $73m Series B Led by IVP to Accelerate Adoption of AI-powered Protein Engineering". Amsterdam & Zurich. |
2024-11-26 |
Metrion Biosciences Ltd.. (11/25/24). "Press Release: Metrion Biosciences Appoints Lee Patterson as CEO". Cambridge. |
2024-11-25 |
Glox Therapeutics Ltd.. (11/20/24). "Press Release: Glox Therapeutics Awarded £1M PACE Grant to Accelerate Development of Precision Antibiotics Against Antimicrobial-resistant Pathogens". Glasgow. |
2024-11-20 |
Tagomics Ltd.. (11/20/24). "Press Release: Tagomics Announces a Multiomic Profiling Co-Marketing Agreement with Agilent". Cambridge. |
2024-11-20 |
Revvity, Inc.. (11/20/24). "Press Release: Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK". Waltham, MA. |
2024-11-20 |
CRISPR Therapeutics AG. (11/14/24). "Press Release: CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference". Zug & Boston, MA. |
2024-11-14 |
Centogene N.V.. (11/13/24). "Press Release: Centogene Signs Strategic Transaction with Private Equity Group Charme Capital Partners [not for release, publication or distribution, where unlawful]". Cambridge, MA & Rostock. |
2024-11-13 |
[iito] Business Intelligence / Kääb, Georg [ Itranskript ]. (11/13/24). "[LSG] Newsletter Special Issue: DACH Region Seed Financings 2020–2024. A List of 104 Deals with Comment & Analysis by Georg Kääb". Bremen & München. |
2024-11-13 |
Kynos Therapeutics Ltd.. (10/29/24). "Press Release: Dr. Falk Pharma Acquires Kynos Therapeutics, Adding Acute Pancreatitis as a Therapeutic Focus and Further Strengthening Its Development Portfolio". Freiburg. |
2024-10-29 |
Inbrain Neuroelectronics S.L.. (10/29/24). "Press Release: Inbrain Neuroelectronics Raises $50M Series B to Advance Graphene-Based Brain-Computer Interface Technology". Barcelona. |
2024-10-29 |
Ottimo Pharma Ltd.. (10/28/24). "Press Release: Ottimo Pharma Emerges from Stealth with Backing from Medicxi and Management Team Led by David Epstein to Accelerate Development of a Novel PD1/VEGFR2 Bi-Functional Antibody Planned to Enter the Clinic in 20 |
2024-10-28 |
ICR Inc.. (10/22/24). "Press Release: ICR Healthcare Launches as a Unified Global Brand in Healthcare Strategic Communications and Investor Relations". New York, NY & London. |
2024-10-22 |
Seaport Therapeutics. (10/21/24). "Press Release: Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round". Boston, MA. |
2024-10-21 |
BenevolentAI Ltd.. (10/17/24). "Press Release: BenevolentAI Appoints Kenneth Mulvany as Executive Chairman". London. |
2024-10-17 |
Nuclera Ltd.. (10/16/24). "Press Release: Nuclera Closes $75 Million USD Financing
> Series C round led by Elevage Medical Technologies". Cambridge & Boston, MA. |
2024-10-16 |
Antiverse Ltd.. (10/15/24). "Press Release: Antiverse Raises £3.5M ($4.6M) to Advance Generative AI Antibody Design Platform". Cardiff. |
2024-10-15 |
Shift Bioscience Ltd.. (10/15/24). "Press Release: Shift Bioscience Raises $16M to Advance Cell Simulation AI Platform". Cambridge. |
2024-10-15 |
Invios GmbH. (10/15/24). "Press Release: Invios Raises €8.2 Million in a Series A to Finance Pipeline Progress in Immuno-oncology". Vienna. |
2024-10-15 |
Cosmo Pharmaceuticals N.V.. (10/11/24). "Press Release: Cosmo Pharmaceuticals Appoints New Chief Financial Officer". Dublin. |
2024-10-11 |
Camp4 Therapeutics Corporation. (10/10/24). "Press Release: Camp4 Announces Pricing of Initial Public Offering". Cambridge, MA. |
2024-10-10 |
Clock Bio Ltd.. (10/9/24). "Press Release: clock.bio Raises $5.3M Seed Funding and Decodes Genetic Atlas of Human Rejuvenation Factors". Cambridge. |
2024-10-09 |
Calluna Pharma AS. (10/9/24). "Press Release: Calluna Pharma Appoints Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Independent Chair of the Board". Oslo & Boston, MA. |
2024-10-09 |
Purespring Therapeutics Ltd.. (10/9/24). "Press Release: Purespring Therapeutics Raises £80/$105 Million in a Series B Financing to Transform the Treatment of Kidney Diseases". London. |
2024-10-09 |
Somagenetix AG. (10/8/24). "Press Release: Somagenetix AG Secures CHF 10 Million in Series A Financing to Advance Lentiviral Gene Therapy for Chronic Granulomatous Disease (CGD)". Zurich. |
2024-10-08 |
Enara Bio Ltd.. (10/3/24). "Press Release: Enara Bio Raises $32.5 Million Series B Financing to Advance First-in-Class Pipeline of TCR-based Immunotherapies Targeting Novel Dark Antigens". Oxford. |
2024-10-03 |
LoQus23 Therapeutics Ltd.. (10/2/24). "Press Release: LoQus23 Therapeutics Announces £35 Million (c.$43 Million) Series A Financing to Advance Its Small Molecule Somatic Expansion Inhibition Therapy for Huntington’s Disease". Cambridge. |
2024-10-02 |
Constructive Biology Ltd.. (9/24/24). "Press Release: Constructive Bio Secures $58 Million in Series A Financing". Cambridge. |
2024-09-24 |
Lift BioSciences Ltd.. (9/24/24). "Press Release: Lift BioSciences Raises £10m in First Close of Series A to Advance First-in-Class Allogeneic Innate Cell Therapy". Milan. |
2024-09-24 |
Cosmo Pharmaceuticals N.V.. (9/23/24). "Press Release: Cosmo Pharmaceuticals Enhances Management Team with Newly Appointed Head of Global Business Development". Dublin. |
2024-09-23 |
Agilent Technologies Inc.. (9/20/24). "Press Release: Agilent Completes Acquisition of Biovectra". Santa Clara, CA. |
2024-09-20 |
Halix B.V.. (9/19/24). "Press Release: Halix Appoints Dr. Lutz Hilbrich as New Chief Executive Officer". Leiden. |
2024-09-19 |
Oribiotech Ltd.. (9/18/24). "Press Release: Ori Biotech and Charles River Laboratories Collaborate to Accelerate Life-Saving Cell and Gene Therapy Development and Manufacturing". Philadeliphia, PA. |
2024-09-18 |
Boehringer Ingelheim Stiftung / ÖAW. (9/18/24). "Press Release: OeAW and Boehringer Ingelheim Foundation Establish New Institute for Biomedical Artificial Intelligence in Vienna". Mainz. |
2024-09-18 |
Bioké (Cell Signaling Technology Europe B.V.). (9/16/24). "Press Release: Bioké and e-Blot Announce a Distribution Agreement in the European Region". Leiden. |
2024-09-16 |
Cellular Origins Ltd.. (9/11/24). "Press Release: Cellular Origins and 3P Innovation Collaborate to Accelerate Industrialisation of CGT Manufacturing". Cambridge. |
2024-09-11 |
Forbion Capital Partners. (9/11/24). "Press Release: Forbion Leads $14m Series A in Solasta Bio to Advance Development and Commercialisation of First-in-class Sustainable Crop Protection Solutions". Naarden. |
2024-09-11 |
Closed Loop Medicine Ltd.. (9/11/24). "Press Release: Closed Loop Medicine Appoints Luba Greenwood as Chair of the Board of Directors". London. |
2024-09-11 |
Agronomics Ltd.. (9/10/24). "Press Release: Formo Closes a US$ 61 Million Series B Round". |
2024-09-10 |
NanoSyrinx Ltd.. (9/10/24). "Press Release: NanoSyrinx Closes £10 Million GBP Financing and Appoints Dr. Edwin Moses as Chairman". Coventry. |
2024-09-10 |
Miltenyi Biotec B.V. & Co. KG. (9/10/24). "Press Release: Miltenyi Biotec Manufactures Lentiviral Vector for Adaptimmune’s FDA-approved TCR T-cell therapy Tecelra (afamitresgeme autoleucel)". Bergisch Gladbach. |
2024-09-10 |
PhoreMost Ltd.. (9/10/24). "Press Release: PhoreMost Extends Series B Financing to $50M to Advance High-value Oncology and Inflammation Degrader Programmes". Cambridge. |
2024-09-10 |
Oxford Nanopore Technologies plc. (9/10/24). "Press Release: Oxford Nanopore Seeks Discovery in Connection with Anticipated Breach of Contract Action". |
2024-09-10 |
Epsilogen Ltd.. (9/9/24). "Press Release: Epsilogen Completes £12.5 Million Series B Financing Expansion". London. |
2024-09-09 |
Genedata AG. (9/5/24). "Press Release: Immunocore Selects Genedata to Scale Up Discovery of Novel TCR Therapeutics". Basel. |
2024-09-05 |
ERS Genomics Ltd.. (9/4/24). "Press Release: ERS Genomics and Medicines Discovery Catapult Sign CRISPR/Cas9 License Agreement". Dublin & Cheshire. |
2024-09-04 |
Evotec SE. (9/3/24). "Press Release: Evotec Announces Change in Management Board. Dr Matthias Evers Steps Down as Chief Business Officer Effective 01 October 2024". Hamburg. |
2024-09-03 |
Nxera Pharma Co., Ltd.. (9/2/24). "Press Release: Nxera Pharma to Receive US$35 Million from Neurocrine Biosciences upon Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568". Tokyo & Cambridge. |
2024-09-02 |
NextRNA Therapeutics, Inc.. (8/28/24). "Press Release: Bayer and NextRNA Therapeutics Enter Strategic Collaboration to Develop Small Molecules Targeting Long Non-coding RNAs (lncRNAs) in Oncology". Berlin & Boston, MA. |
2024-08-28 |
Qiagen N.V.. (8/28/24). "Press Release: Qiagen Expands QIAstat-Dx into Precision Medicine through Partnership for Companion Diagnostics in Chronic Diseases". Venlo. |
2024-08-28 |
Exscientia plc. (8/28/24). "Press Release: Exscientia to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference". Oxford. |
2024-08-28 |
BRAIN Biotech AG. (8/22/24). "Press Release: BRAIN Biotech AG Launches the Innovative Technology Platform MetXtra Enabling Unique Enzyme Solutions". Zwingenberg. |
2024-08-22 |
BioArctic AB. (8/22/24). "Press Release: Leqembi (lecanemab) Authorized for Early Alzheimer’s Disease in Great Britain". Stockholm. |
2024-08-22 |
BoobyBiome Ltd.. (8/22/24). "Press Release: BoobyBiome Secures £1.6M Innovate UK Biomedical Catalyst Grant for Groundbreaking Synbiotic Research". London. |
2024-08-22 |
Coulter Partners. (8/22/24). "Press Release: Coulter Partners Places Industry Veteran Dr. David Hung as Chair of T-Therapeutics". |
2024-08-22 |
Supreme Optimization. (8/21/24). "Press Release: Supreme Group Acquires BioStrata, an Award-Winning UK-Based Life Science Marketing and Public Relations Agency". West Chester, PA & Cambridge. |
2024-08-21 |
Reliant AI, Inc.. (8/20/24). "Press Release: Gen AI Analytics Provider, Reliant AI, Launches with $11.3m in Seed Funding". Montréal, QC & Berlin. |
2024-08-20 |
Fujifilm Diosynth Biotechnologies UK Ltd.. (8/20/24). "Press Release: Fujifilm Diosynth Biotechnologies Celebrates Opening of Billingham, UK Microbial Manufacturing Facility". Billingham. |
2024-08-20 |
Caresyntax. (8/15/24). "Press Release: Caresyntax Raises $180 Million Funding to Accelerate Growth and Adoption of Precision Surgery". San Francisco, CA & Berlin. |
2024-08-15 |
Marinomed Biotech AG. (8/14/24). "Press Release: Marinomed Biotech AG Aims for Financial Reorganization by Restructuring Proceedings without Self-administration". Korneuburg. |
2024-08-14 |
Balderton Capital. (8/12/24). "Press Release: Balderton Announces $1.3B in New Funds to Back Europe’s Top Entrepreneurs as They Build World-changing Businesses". |
2024-08-12 |
MeiraGTx Holdings plc. (8/12/24). "Press Release: MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi". London & New York, NY. |
2024-08-12 |
Recursion Pharmaceuticals, Inc.. (8/8/24). "Press Release: Recursion and Exscientia Enter Definitive Agreement to Create a Global Technology-Enabled Drug Discovery Leader with End-to-End Capabilities". Salt Lake City, UT & Oxford. |
2024-08-08 |
Carbios S.A.. (8/6/24). "Press Release: Carbios and FCC Environment Announce Joint Project to Establish UK-based PET Biorecycling Facility Using Carbios’ Licensed Technology". Clermont-Ferrand & Doncaster. |
2024-08-06 |
Adaptimmune Therapeutics plc. (8/1/24). "Press Release: Adaptimmune Receives U.S. FDA Accelerated Approval of TECELRA® (afamitresgene autoleucel), the First Approved Engineered Cell Therapy for a Solid Tumor". Philadeliphia, PA & Oxford. |
2024-08-01 |
iotaSciences Ltd.. (7/31/24). "Press Release: iotaSciences Raises Equity Financing Round to Drive further Business Expansion for Its Automated Single-cell Biology Handling Technologies". Oxford. |
2024-07-31 |
Flo Health UK Ltd.. (7/30/24). "Press Release: Flo Health Secures More than $200M Investment from General Atlantic to Revolutionize Women’s Health; First Purely Digital Consumer Women’s Health App to Achieve Unicorn Status". London. |
2024-07-30 |
Montara Therapeutics, Inc.. (7/30/24). "Press Release: Montara Therapeutics Closes $8 Million Seed Round Led by SV Health Investors’ Dementia Discovery Fund and Two Bear Capital". San Francisco, CA. |
2024-07-30 |
4basebio plc. (7/29/24). "Press Release: 4basebio plc Announces £40.0 Million Equity Issuance and £29.4 Million Secondary Sale". |
2024-07-29 |
Deepc GmbH. (7/24/24). "Press Release: Deepc Closes Series A Extension to Accelerate Global Deployment of Healthcare AI, Bringing Total Funding to $30m". Munich. |
2024-07-25 |
Kadans Science Partner. (7/24/24). "Press Release: Kadans Science Partner Commences Work on New Purpose-built Wet Lab Facilities at Merlin Place, North Cambridge". Cambridge. |
2024-07-24 |